Malaysia Gets Cheaper Access To Key HIV Drug
1 Dec 2020
CodeBlue
The recent price for Tivicay in Malaysia, Azerbaijan, Belarus, and Kazakhstan was reportedly between US$1,800 (RM7,345) and US$2,160 (RM8,814) per patient annually. Scanning electron micrograph of HIV-1 budding (in green) from cultured lymphocyte.